Cite
Weekly carboplatin plus neoadjuvant anthracycline-taxane-based regimen in early triple-negative breast cancer: a prospective phase II trial by the Breast Cancer Task Force of the Belgian Society of Medical Oncology (BSMO).
MLA
UCL - SSS/IREC/MONT - Pôle Mont Godinne, et al. “Weekly Carboplatin plus Neoadjuvant Anthracycline-Taxane-Based Regimen in Early Triple-Negative Breast Cancer: A Prospective Phase II Trial by the Breast Cancer Task Force of the Belgian Society of Medical Oncology (BSMO).” Breast Cancer Research and Treatment, Vol. 176, No. 3, p. 607-615 (2019), 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1104520521&authtype=sso&custid=ns315887.
APA
UCL - SSS/IREC/MONT - Pôle Mont Godinne, UCL - (MGD) Service d’oncologie médicale, Fontaine, C., Renard, V., Van den Bulk, H., Vuylsteke, P., Glorieux, P., Dopchie, C., Decoster, L., Vanacker, L., de Azambuja, E., De Greve, J., Awada, A., & Wildiers, H. (2019). Weekly carboplatin plus neoadjuvant anthracycline-taxane-based regimen in early triple-negative breast cancer: a prospective phase II trial by the Breast Cancer Task Force of the Belgian Society of Medical Oncology (BSMO). Breast Cancer Research and Treatment, Vol. 176, No. 3, p. 607-615 (2019).
Chicago
UCL - SSS/IREC/MONT - Pôle Mont Godinne, UCL - (MGD) Service d’oncologie médicale, Christel Fontaine, Vincent Renard, Heidi Van den Bulk, Peter Vuylsteke, Philip Glorieux, et al. 2019. “Weekly Carboplatin plus Neoadjuvant Anthracycline-Taxane-Based Regimen in Early Triple-Negative Breast Cancer: A Prospective Phase II Trial by the Breast Cancer Task Force of the Belgian Society of Medical Oncology (BSMO).” Breast Cancer Research and Treatment, Vol. 176, No. 3, p. 607-615 (2019). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1104520521&authtype=sso&custid=ns315887.